Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31726 - 31750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	HSPA1A	3303	upregulated	Cisplatin results in increased expression of HSPA1A mRNA	6p21.33	A22204
Cisplatin	Approved Investigational	HSPA1B	3304	downregulated	Cisplatin results in decreased expression of HSPA1B mRNA	6p21.33	A20427
Cisplatin	Approved Investigational	HSPA1B	3304	upregulated	Cisplatin results in increased expression of HSPA1B mRNA	6p21.33	A22204
Cisplatin	Approved Investigational	HSPA5	3309	downregulated	Cisplatin results in decreased expression of HSPA5 mRNA	9q33.3	A22210 A20427
Cisplatin	Approved Investigational	HSPA5	3309	upregulated	Cisplatin results in increased expression of HSPA5 mRNA	9q33.3	A22204
Cisplatin	Approved Investigational	HSPA6	3310	upregulated	Cisplatin results in increased expression of HSPA6 mRNA	1q23.3	A22204 A22211
Cisplatin	Approved Investigational	IARS	3376	upregulated	Cisplatin results in increased expression of IARS mRNA	9q22.31	A20427
Cisplatin	Approved Investigational	ICAM1	3383	upregulated	Cisplatin results in increased expression of ICAM1 mRNA	19p13.2	A22203
Cisplatin	Approved Investigational	ID2	3398	upregulated	Cisplatin results in increased expression of ID2 mRNA	2p25.1	A22204 A22211
Cisplatin	Approved Investigational	ID3	3399	downregulated	Cisplatin results in decreased expression of ID3 mRNA	1p36.12	A21499
Cisplatin	Approved Investigational	IDI2-AS1	55853	upregulated	Cisplatin results in increased stability of and results in increased expression of IDI2-AS1 mRNA	10p15.3	A22245
Cisplatin	Approved Investigational	IDS	3423	downregulated	Cisplatin results in decreased expression of IDS mRNA	Xq28	A20427
Cisplatin	Approved Investigational	IER2	9592	upregulated	Cisplatin results in increased expression of IER2 mRNA	19p13.13	A22203
Cisplatin	Approved Investigational	IER3	8870	upregulated	Cisplatin results in increased expression of IER3 mRNA	6p21.33	A22212 A21978
Cisplatin	Approved Investigational	IER5	51278	upregulated	Cisplatin results in increased expression of IER5 mRNA	1q25.3	A22212
Cisplatin	Approved Investigational	IGF2BP2	10644	downregulated	Cisplatin results in decreased expression of IGF2BP2 mRNA	3q27.2	A22204
Cisplatin	Approved Investigational	IGFBP3	3486	downregulated	Cisplatin results in decreased expression of IGFBP3 mRNA	7p12.3	A22213
Cisplatin	Approved Investigational	IGFBP3	3486	upregulated	Cisplatin results in increased expression of IGFBP3 mRNA	7p12.3	A22212
Cisplatin	Approved Investigational	IGFBP5	3488	downregulated	Cisplatin results in decreased expression of IGFBP5 mRNA	2q35	A20660
Cisplatin	Approved Investigational	IGFBP6	3489	upregulated	Cisplatin results in increased expression of IGFBP6 mRNA	12q13.13	A22236
Cisplatin	Approved Investigational	IL11	3589	upregulated	Cisplatin results in increased expression of IL11 mRNA	19q13.42	A22204
Cisplatin	Approved Investigational	IL12A	3592	upregulated	Cisplatin results in increased expression of IL12A mRNA	3q25.33	A22204
Cisplatin	Approved Investigational	IL4R	3566	upregulated	Cisplatin results in increased expression of IL4R mRNA	16p12.1	A22252
Cisplatin	Approved Investigational	INPP5A	3632	downregulated	Cisplatin results in decreased expression of INPP5A mRNA	10q26.3	A22204
Cisplatin	Approved Investigational	IRS1	3667	downregulated	Cisplatin results in decreased expression of IRS1 mRNA	2q36.3	A22204

Displaying entries 31726 - 31750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability